Cathie Wood
WST icon

Cathie Wood’s West Pharmaceutical WST Stock Holding History

Cathie Wood’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-417
Closed -$129K – 335
2022
Q2 		$129K Sell
417
-19
-4% -$6.18K ﹤0.01% 316
2022
Q1 		$179K Buy
+436
New +$171K ﹤0.01% 327

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cathie Wood's WST Position: Q3 2022 in Review

Cathie Wood sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 417 shares — an estimated $129K sold.

Cathie Wood first reported a position in WST in Q1 2022 and held it in 2 quarters. The position peaked at $179K in Q1 2022. 639 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Cathie Wood reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Cathie Wood sold 417 West Pharmaceutical shares in Q3 2022, an estimated $129K.
  • Cathie Wood first reported a position in West Pharmaceutical in Q1 2022 and held it in 2 quarters.
  • Cathie Wood's West Pharmaceutical position peaked at $179K in Q1 2022.
  • 639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.